Vanguard Fiduciary Trust »

Crispr Therapeutics shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $26M 543k 47.57

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
T. Rowe Price Investment Management
Geode Capital Management
Vanguard Group
Susquehanna International
Sr One Capital Management
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
UBS Group
Two Sigma Investments

View all funds holding Crispr Therapeutics